The effect of quercetin and berberine on pulmonary arterial hypertensio

Phase 3

• Conditions: pulmonary arterial hypertension.; Other secondary pulmonary hypertension; I27.2

• Registration Number: IRCT20230220057462N1
• Lead Sponsor: Bam University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Patients with pulmonary artery hypertension

Exclusion Criteria

Liver disease
kidney Diseases
diabetes
Specific diseases such as cancer and known vascular diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
People with pulmonary artery peak systolic pressure >35 mm Hg. Timepoint: The first and last days of study. Method of measurement: Echocardiography.